Gómez-Aparicio, M.A.; López-Campos, F.; Buchser, D.; Lazo, A.; Willisch, P.; Ocanto, A.; Sargos, P.; Shelan, M.; Couñago, F.
Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer? Cancers 2024, 16, 2331.
https://doi.org/10.3390/cancers16132331
AMA Style
Gómez-Aparicio MA, López-Campos F, Buchser D, Lazo A, Willisch P, Ocanto A, Sargos P, Shelan M, Couñago F.
Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer? Cancers. 2024; 16(13):2331.
https://doi.org/10.3390/cancers16132331
Chicago/Turabian Style
Gómez-Aparicio, MarÃa Antonia, Fernando López-Campos, David Buchser, Antonio Lazo, Patricia Willisch, Abrahams Ocanto, Paul Sargos, Mohamed Shelan, and Felipe Couñago.
2024. "Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?" Cancers 16, no. 13: 2331.
https://doi.org/10.3390/cancers16132331
APA Style
Gómez-Aparicio, M. A., López-Campos, F., Buchser, D., Lazo, A., Willisch, P., Ocanto, A., Sargos, P., Shelan, M., & Couñago, F.
(2024). Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer? Cancers, 16(13), 2331.
https://doi.org/10.3390/cancers16132331